| Financial Year |
March 31 2023 |
| Monetary Funds |
234,897,275.04 |
| Held-for-trading Financial Assets |
243,454.50 |
| Notes Receivable |
425,352,973.87 |
| Accounts Receivable |
1,184,130,234.43 |
| Advances to Suppliers |
38,354,936.74 |
| Other Receivables |
14,590,888.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
681,734,515.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,995,360.29 |
| Total Current Assets |
2,642,422,863.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
66,155,443.05 |
| Fixed Assetes |
390,310,556.53 |
| Under-construction Projects |
74,490,139.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
76,353,492.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
97,421.92 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
619,333,909.75 |
| Total Assets |
3,261,756,772.87 |
| Short-Term Loans |
698,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
459,220,268.41 |
| Accounts Payable |
1,306,376,220.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,638,985.36 |
| Taxes Payable |
14,241,606.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
184,961,516.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
3,313,615.86 |
| Sub-Total of Current Liabilities |
2,708,548,593.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
344,974.84 |
| Special Payable |
-- |
| Estimatied Liabilities |
54,613,759.15 |
| Deferred Income Tax Liabilities |
626,909.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
102,834,910.99 |
| Total Liabilities |
2,811,383,504.16 |
| Paid-In Capital(Or Share Stock) |
402,600,000.00 |
| Capital Surplus |
485,691,050.47 |
| Surplus Reserve |
136,770,391.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-579,428,062.53 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
450,373,268.71 |
| Owner's Equity（Stockholder's Equity） |
450,373,268.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,261,756,772.87 |
